State Street Corp Verrica Pharmaceuticals Inc. Transaction History

State Street Corp

$2.25 Trillion
Q2 2024

A detailed history of State Street Corp transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, State Street Corp holds 451,780 shares of VRCA stock, worth $3.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

451,780

Previous 412,603 9.5%

Holding current value

$3.59 Million

Previous $2.44 Million 34.85%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.89 - $9.56 $230,752 - $374,532	39,177 Added 9.5%	451,780 $3.29 Million
Q1 2024 May 15, 2024	BUY	$4.74 - $6.81 $110,612 - $158,918	23,336 Added 5.99%	412,603 $2.44 Million
Q4 2023 Feb 14, 2024	BUY	$2.93 - $7.32 $19,115 - $47,755	6,524 Added 1.7%	389,267 $2.85 Million
Q3 2023 Nov 14, 2023	BUY	$3.75 - $7.46 $24,870 - $49,474	6,632 Added 1.76%	382,743 $1.49 Million
Q2 2023 Aug 14, 2023	BUY	$5.32 - $6.79 $1.64 Million - $2.09 Million	308,395 Added 455.42%	376,111 $2.17 Million
Q1 2023 May 15, 2023	BUY	$2.88 - $8.51 $14,112 - $41,699	4,900 Added 7.8%	67,716 $440,000
Q3 2022 Nov 15, 2022	SELL	$2.17 - $4.3 $43,400 - $86,000	-20,000 Reduced 24.15%	62,816 $183,000
Q2 2022 Aug 15, 2022	SELL	$1.81 - $8.93 $268,276 - $1.32 Million	-148,219 Reduced 64.15%	82,816 $159,000
Q1 2022 May 16, 2022	BUY	$7.59 - $9.49 $35,058 - $43,834	4,619 Added 2.04%	231,035 $1.87 Million
Q4 2021 Feb 14, 2022	SELL	$9.1 - $13.36 $11,193 - $16,432	-1,230 Reduced 0.54%	226,416 $2.07 Million
Q3 2021 Nov 15, 2021	BUY	$9.55 - $13.96 $127,005 - $185,654	13,299 Added 6.2%	227,646 $2.85 Million
Q2 2021 Aug 16, 2021	SELL	$9.77 - $15.33 $39,109 - $61,365	-4,003 Reduced 1.83%	214,347 $2.42 Million
Q1 2021 May 17, 2021	SELL	$10.51 - $17.46 $50,742 - $84,296	-4,828 Reduced 2.16%	218,350 $3.31 Million
Q4 2020 Feb 16, 2021	SELL	$7.41 - $12.63 $69,646 - $118,709	-9,399 Reduced 4.04%	223,178 $2.57 Million
Q3 2020 Nov 10, 2020	SELL	$6.16 - $10.3 $24,134 - $40,355	-3,918 Reduced 1.66%	232,577 $1.8 Million
Q2 2020 Aug 14, 2020	BUY	$9.02 - $15.12 $15,279 - $25,613	1,694 Added 0.72%	236,495 $2.6 Million
Q1 2020 May 11, 2020	BUY	$7.14 - $16.86 $1.68 Million - $3.96 Million	234,801 New	234,801 $2.57 Million

Others Institutions Holding VRCA

# of Institutions

Shares Held

17.4M

Call Options Held

6.1K

Put Options Held

6.3K

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Verrica Pharmaceuticals Inc. Transaction History